Angeles Estelles
Overview
Explore the profile of Angeles Estelles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryser S, Tenorio E, Estelles A, Kauvar L
PLoS One
. 2019 Jul;
14(7):e0219256.
PMID: 31287831
We have previously described a native human monoclonal antibody, TRL1068, that disrupts bacterial biofilms by extracting from the biofilm matrix key scaffolding proteins in the DNABII family, which are present...
2.
Vigil A, Estelles A, Kauvar L, Johnson S, Tripp R, Wittekind M
Antimicrob Agents Chemother
. 2018 Mar;
62(5).
PMID: 29507069
Although antibodies that effectively neutralize a broad set of influenza viruses exist in the human antibody repertoire, they are rare. We used a single-cell screening technology to identify rare monoclonal...
3.
Ryser S, Estelles A, Tenorio E, Kauvar L, Gishizky M
PLoS One
. 2017 Jul;
12(7):e0181464.
PMID: 28723950
We report here the cloning of native high affinity anti-TIM-3 and anti-KIR IgG monoclonal antibodies (mAbs) from peripheral blood mononuclear cells (PBMC) of healthy human donors. The cells that express...
4.
Xiong Y, Estelles A, Li L, Abdelhady W, Gonzales R, Bayer A, et al.
Antimicrob Agents Chemother
. 2017 Jul;
61(10).
PMID: 28717038
Many serious bacterial infections are antibiotic refractory due to biofilm formation. A key structural component of biofilm is extracellular DNA, which is stabilized by bacterial proteins, including those from the...
5.
Estelles A, Woischnig A, Liu K, Stephenson R, Lomongsod E, Nguyen D, et al.
Antimicrob Agents Chemother
. 2016 Feb;
60(4):2292-301.
PMID: 26833157
Many serious bacterial infections are difficult to treat due to biofilm formation, which provides physical protection and induces a sessile phenotype refractory to antibiotic treatment compared to the planktonic state....
6.
Kashyap A, Steel J, Rubrum A, Estelles A, Briante R, Ilyushina N, et al.
PLoS Pathog
. 2010 Jul;
6(7):e1000990.
PMID: 20628565
Influenza viruses elude immune responses and antiviral chemotherapeutics through genetic drift and reassortment. As a result, the development of new strategies that attack a highly conserved viral function to prevent...
7.
Xu L, Estelles A, Briante R, Kurtzman A, Hannum C, Kashyap A, et al.
J Mol Biol
. 2010 Jan;
397(1):352-60.
PMID: 20100493
Surrobodies(2) are a unique type of binding protein based on the pre-B-cell receptor (pre-BCR). The pre-BCR is transiently expressed during development of the antibody repertoire. Unlike heterotetrameric canonical antibodies that...
8.
Estelles A, Sperinde J, Roulon T, Aguilar B, Bonner C, LePecq J, et al.
Int J Nanomedicine
. 2008 Jan;
2(4):751-60.
PMID: 18203441
Exosomes are naturally occurring nanovesicles that can be tailored to display a broad range of drug targets, including G protein-coupled receptors. Such vesicles provide a new source of complex membrane...
9.
Delcayre A, Estelles A, Sperinde J, Roulon T, Paz P, Aguilar B, et al.
Blood Cells Mol Dis
. 2005 Aug;
35(2):158-68.
PMID: 16087368
Exosome Display is a novel methodology enabling the manipulation of exosome protein content. This technology stems from the identification of addressing domains that mediate the specific distribution of proteins on...